Form 4 for HAE HAEMONETICS CORP
Accepted 2025-11-03 00:00:00 ET · period of report 2025-10-31 · accession 0000313143-25-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-03 | 2025-10-31 | HAE | Galvin Roy | EVP, Chief Commercial Off | F - Tax | $50.01 | -145 | 12.8K | -1% | -$7,251 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | F | D | 145 | $50.01 | 12,811 | D | — | — | (F1) Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. (F2) This number includes unvested RSUs previously reported as well as 24 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2025. |